We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $357M
1-Year Est. Return 13.97%
This Fund
S&P 500
This Quarter Est. Return
+25.5%
1 Year Est. Return
+13.97%
3 Year Est. Return
+50.79%
5 Year Est. Return
+74.78%
10 Year Est. Return
+368.42%
AUM
$5.64B
AUM Growth
+$763M
Cap. Flow
-$277M
Cap. Flow %
-4.92%
Top 10 Hldgs %
23.75%
Holding
2,653
New
149
Increased
768
Reduced
1,024
Closed
109

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$6.19M
2
ABBV icon
AbbVie
ABBV
+$5.01M
3
DXCM icon
DexCom
DXCM
+$4.28M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$4.01M
5
PG icon
Procter & Gamble
PG
+$3.96M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$53.5M
2
CSCO icon
Cisco
CSCO
+$10.3M
3
AGN
Allergan plc
AGN
+$8.8M
4
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$7.52M
5
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$7M

Sector Composition

Rank Sector Weight
1 Technology 24.07%
2 Healthcare 14.46%
3 Financials 11.96%
4 Consumer Discretionary 10.97%
5 Communication Services 8.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VYX icon
1326
NCR Voyix
VYX
$1.14B
$429K 0.01%
40,364
-24,536
-38% -$281K
RVNC
1327
DELISTED
Revance Therapeutics, Inc.
RVNC
$429K 0.01%
17,562
+1,976
+13% +$39K
HEI.A icon
1328
HEICO Corp Class A
HEI.A
$37.9B
$429K 0.01%
5,277
-127
-2% -$9.85K
CMPR icon
1329
Cimpress
CMPR
$2.35B
$428K 0.01%
5,605
– –
GTY
1330
Getty Realty Corp
GTY
$2.06B
$428K 0.01%
14,409
+1,401
+11% +$37.1K
MXL icon
1331
MaxLinear
MXL
$7.5B
$427K 0.01%
19,905
– –
PTLA
1332
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$426K 0.01%
23,656
– –
ARNC
1333
DELISTED
Arconic Corporation
ARNC
$425K 0.01%
+30,529
New +$358K
DBX icon
1334
Dropbox
DBX
$7.53B
$424K 0.01%
19,498
+4,667
+31% +$98.6K
NTB icon
1335
Bank of N.T. Butterfield & Son
NTB
$2.51B
$424K 0.01%
17,400
– –
YUMC icon
1336
Yum China
YUMC
$16.2B
$424K 0.01%
8,812
-13,381
-60% -$631K
APO icon
1337
Apollo Global Management
APO
$83.5B
$423K 0.01%
+8,471
New +$372K
ADUS icon
1338
Addus HomeCare
ADUS
$2.18B
$423K 0.01%
4,567
+477
+12% +$41.3K
ITCI
1339
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$422K 0.01%
16,452
– –
TNDM icon
1340
Tandem Diabetes Care
TNDM
$1.58B
$422K 0.01%
4,269
-12,691
-75% -$1.01M
LNW
1341
DELISTED
Light & Wonder
LNW
$422K 0.01%
27,277
-3,584
-12% -$46.8K
SDGR icon
1342
Schrodinger
SDGR
$1.33B
$422K 0.01%
4,605
– –
ACAD icon
1343
Acadia Pharmaceuticals
ACAD
$4.84B
$421K 0.01%
8,688
-25,006
-74% -$1.2M
TWST icon
1344
Twist Bioscience
TWST
$7.49B
$421K 0.01%
9,284
+1,696
+22% +$60.9K
AN icon
1345
AutoNation
AN
$6.91B
$420K 0.01%
11,184
-4,373
-28% -$158K
VGR
1346
DELISTED
Vector Group Ltd.
VGR
$419K 0.01%
58,715
+11,143
+23% +$85.1K
OPK icon
1347
Opko Health
OPK
$1B
$416K 0.01%
122,006
-48
-0% -$108
SSNC icon
1348
SS&C Technologies
SSNC
$18.9B
$415K 0.01%
7,351
-7,196
-49% -$392K
KN icon
1349
Knowles
KN
$3.33B
$415K 0.01%
27,202
+2,257
+9% +$33.7K
GTN icon
1350
Gray Television
GTN
$530M
$415K 0.01%
29,749
– –
52 53
54
55 56

Similar funds

RM
Rudius Management New York $358M AUM 12.23% 1-Year Est. Return
SPM
Symmetry Peak Management Radnor, Pennsylvania $359M AUM 146.87% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 8.03% 1-Year Est. Return
SFP
Sandbox Financial Partners Bethesda, Maryland $356M AUM 19.83% 1-Year Est. Return
RIP
Rhino Investment Partners West Conshohocken, Pennsylvania $359M AUM 22.33% 1-Year Est. Return
KLWA
Kelly Lawrence W & Associates Pasadens, California $360M AUM 16.9% 1-Year Est. Return
LSC
Logan Stone Capital Chicago, Illinois $360M AUM 9.71% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s Q2 2020 Portfolio in Review

As of Q2 2020, Metropolitan Life Insurance Company (MetLife) held 2,653 positions worth $5.64B, up 16% from $4.87B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Metropolitan Life Insurance Company (MetLife) withdrew a net $277M in Q2 2020, closing 109 positions and reducing 1,024 holdings. Its most notable exit was Allergan plc, an estimated $8.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Metropolitan Life Insurance Company (MetLife) opened a new position in Otis Worldwide worth $3.26M.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q2 2020 buy was Otis Worldwide: 57,385 shares worth $3.26M.
  • Metropolitan Life Insurance Company (MetLife) added most to Amazon in Q2 2020, an estimated $6.19M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $53.5M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Allergan plc in Q2 2020, selling an estimated $8.8M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 24% of its $5.64B portfolio in Q2 2020.
  • Metropolitan Life Insurance Company (MetLife) opened 149 new positions and closed 109 in Q2 2020.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 16% quarter-over-quarter to $5.64B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2020, filed 14 Aug 2020.